About Us
About Guard Therapeutics
Vision, Business Model & Goal
The Board
Management
Research
Kidney disease
Science
Pipeline
RMC-035
GTX Peptides
Investor Relations
Financial calender
Financial reports
Share information
Corporate governance
General meetings
Rights Issue 2025
Newsroom
Press releases
Event calender
Analyses and presentations
Subscribe
Contact
Swe
Search
Analyses and presentations
Corporate Presentation
Corporate presentation
May 2025
Analyses
08 Apr 2025 / Carnegie Access 8 April 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250408.pdf
17 Mar 2025 / Carnegie Access news flash 14 March 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250314-news-flash.pdf
18 Feb 2025 / Carnegie Access 17 February 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250217.pdf
10 Jan 2025 / Carnegie Access 9 January 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250109.pdf
20 Sep 2023 / Erik Penser Bank - Guard Analysis 20 September 2023
https://guardtherapeutics.com/assets/uploads/Penser20230920-eng.pdf
Presentations & interviews
17 Oct 2024 / Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"
https://www.redeye.se/videoiframe/1044029
23 Sep 2024 / CEO Tobias Agervald appears on BiotechTV
https://www.biotechtv.com/post/guard-therapeutics-september-21-2024
19 Sep 2024 / Presentation at Pareto Securities' 15th Annual Healthcare Conference
https://guardtherapeutics.com/assets/uploads/Guard-Tx-Pareto-19Sept2024-final.pdf
30 Jan 2024 / Guard Therapeutics R&D update January 30, 2024
https://youtube.com/live/Enob5jUFw8I
23 Nov 2023 / Tobias Agervald presents at ABGSC Investor Days
https://www.youtube.com/watch?v=e2-bDLGMznk&list=PLgLifPc-PiGOhe-TjD_5jry8sc-EVJAoK&index=38
19 Sep 2023 / Presentation from Investor Webcast - AKITA Top-line results
https://guardtherapeutics.com/assets/uploads/Webcast-presentation-top-line-results_19-Sept-2023.pdf